What's breaking now, across thousands of outlets.
(RTTNews) - Teva Pharmaceutical Industries Limited (TEVA) presented new efficacy and safety data for ecopipam, an investigational, first-in-class selective dopamine D1 receptor antagonist being developed for pediatric patients with Tourette syndrome.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The Minister of Health, Kwabena Mintah Akandoh, says Ghana will use the 10-month Mercy Ships mission to expand access to specialist healthcare while strengthening the skills of local health…
The Central Regional Command of the Ghana Prisons Service has launched a Medicine and Equipment Bank to mobilise medicines and medical supplies for prisons across the region.
The Punjab government has approved Rs. 45.13 billion for three major health programs, with funds to be released on the … Read More The post Punjab Approves Rs.
A recent study found that a lack of REM and deep sleep is linked to higher risks of dozens of diseases. Credit: Getty A new study analyzing wrist tracker data from 95,000 people found that higher…
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
A new study published in the Journal of Mental Health suggests that some forms of screen time can be beneficial to mental well-being.
